Eri Arikawa-Hirasawa Selected Research

Eri Arikawa-Hirasawa Research Topics

3	Knee Osteoarthritis 01/2017 - 06/2011
2	Dyssegmental dysplasia 01/2022 - 05/2002
2	Muscular Atrophy (Muscle Atrophy) 11/2020 - 04/2014
2	Atrophy 11/2020 - 04/2014
2	Osteophyte 01/2017 - 04/2013
2	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 08/2015 - 05/2002
2	Myotonic Disorders (Paramyotonia Congenita) 04/2012 - 05/2002
1	Aortic Dissection 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2019
1	Neoplasms (Cancer) 10/2019
1	Ischemic Stroke 10/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2019
1	Infarction (Infarctions) 10/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019
1	Corneal Neovascularization 12/2018
1	Hirschsprung Disease (Hirschsprung's Disease) 02/2018
1	Fatty Liver 01/2018
1	Obesity 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Pathologic Neovascularization 03/2016
1	Muscular Diseases (Myopathy) 10/2015
1	Myotonia 08/2015
1	Potassium aggravated myotonia 04/2012
1	Hyperkalemic Periodic Paralysis 04/2012
1	Experimental Sarcoma 07/2010
1	Hypertrophy 07/2010
1	Schizophrenia (Dementia Praecox) 04/2010
1	Tardive Dyskinesia 04/2010
1	Muscular Dystrophies (Muscular Dystrophy) 07/2008
1	Atherosclerosis 10/2004

12	perlecanIBA 01/2022 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2018
3	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2019 - 10/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2020 - 04/2014
2	UbiquitinIBA 11/2020 - 04/2014
2	Laminin (Merosin)IBA 07/2010 - 07/2008
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 11/2020
1	fibulinIBA 10/2019
1	Angiopoietin-1IBA 10/2019
1	Biological ProductsIBA 10/2019
1	IntegrinsIBA 10/2019
1	Endothelin Receptors (Endothelin Receptor)IBA 02/2018
1	laminin AIBA 02/2018
1	LipidsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Muscle Proteins (Muscle Protein)IBA 10/2015
1	Sodium Channels (Sodium Channel)IBA 04/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	MyostatinIBA 07/2010
1	Antipsychotic Agents (Antipsychotics)IBA 04/2010
1	Dopamine AntagonistsIBA 04/2010
1	P-2 (P 2)IBA 04/2010
1	Lipoproteins (Lipoprotein)IBA 10/2004
1	LDL Receptors (LDL Receptor)IBA 10/2004
1	Apolipoproteins E (ApoE)IBA 10/2004
1	ApolipoproteinsIBA 10/2004

2	Denervation 11/2020 - 04/2014
2	Therapeutics 03/2016 - 04/2013